Adam’s starting skills were funnels, copy, creative research, and imagery. He describes applying them to an internal AI production system.

He reports producing roughly 6,000–6,500 new ads per month. The conversation does not disclose the system, model, costs, or win rate.

The creative mix still includes human footage, cut down and spliced into ads. Production volume alone does not establish campaign performance.

Adam argues that existing pharmaceutical advertising creates category awareness in the US. He therefore emphasizes demand capture for this offer.

His message shifts toward availability, provider trust, care, and real customer support rather than a long introduction to the category.

The call to action asks people to see if they qualify. This is his marketing example, not a promise of eligibility or treatment outcomes.

Adam warns that launching ten flagship products at once overlooks the work needed for each offer.

He describes adding one or two products per quarter, supported by favorable timing and investment in talent.

Each addition requires product research, customer understanding, and operational capacity. A larger catalog creates more work than another landing page.

Adam attributes cost control and service quality to proprietary systems, a pharmacy, and a doctor network. These are his descriptions of the operation.

He treats acquisition cost and lifetime value as a paired problem: improve the cost of winning a customer and the value of serving them.

He places the durable advantage after purchase. The landing page is only the visible entry point into the business.